OPKO Health
Overview
OPKO Health is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets. It operates through two segments: Diagnostics, which includes the clinical laboratory operations of BioReference, and Pharmaceuticals, which has operations in several countries and focuses on research and development. The company's products include treatments for kidney disease and growth hormone deficiency, as well as diagnostic tests like the 4Kscore for prostate cancer. While its primary function is not investment, it makes strategic acquisitions and investments in other companies.
Portfolio Companies
2
Website
opko.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| HealthSnap | Nov 2021 | VC Round | Lead |
| ElkosRx, LLC | Aug 2017 | Series C | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is OPKO Health based?
OPKO Health is headquartered in Miami, Florida, United States.
When was OPKO Health founded?
Founding year information for OPKO Health is not publicly available.
How many portfolio companies does OPKO Health have?
OPKO Health has 2 portfolio companies in Caplight's dataset.
What are some companies in OPKO Health's portfolio?
Portfolio companies visible on Caplight include HealthSnap, ElkosRx, LLC.
What was OPKO Health's most recent investment shown here?
OPKO Health's most recent investment in this portfolio sample was in HealthSnap in 2021.
What sectors does OPKO Health focus on?
OPKO Health focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software.
What company stages does OPKO Health focus on?
OPKO Health typically invests at the Mid stage.